Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
kr72.56 Mil
% of Total Estimate Gain
49.93%

VIP International Capital Appreciation Portfolio's Novo Nordisk AS Holding Summary

As of 2025-03-31, VIP International Capital Appreciation Portfolio held - shares of Novo Nordisk AS(OCSE:NOVO B), totaling N/A. This investment constitutes 0% of their stock portfolio, and VIP International Capital Appreciation Portfolio now holds 0% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.

The initial trade took place in 2019Q4. And since then VIP International Capital Appreciation Portfolio has made 7 purchases of OCSE:NOVO B, at an average price of kr267.35, for a total of 543,553.00 shares. In addition, there have been 13 sales at an average price of kr400.84 for 543,553.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, VIP International Capital Appreciation Portfolio's estimated gain on his OCSE:NOVO B holdings is kr72.56 Mil, reflecting a 49.93% gain to date.

VIP International Capital Appreciation Portfolio OCSE:NOVO B (kr423.90) Holding Chart

VIP International Capital Appreciation Portfolio OCSE:NOVO B (kr423.90) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price kr-/Share
Shares Sold 0 Average Price kr-/Share
Current Price kr0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1